Rapamycin: Another San Antonio biotech changing its name and CEO
The changes are expected to bring the Alamo City company's initial compound closer to commercialization.
Read full article »
Rapamycin manufactures and commercializes sirolimus-based drugs for the treatment of dementia, cancer and autoimmune diseases.
Read more